X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5071) 5071
Publication (323) 323
Book Review (76) 76
Magazine Article (35) 35
Book / eBook (20) 20
Conference Proceeding (9) 9
Book Chapter (5) 5
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4379) 4379
male (2679) 2679
anti-anxiety agents - adverse effects (2521) 2521
anti-anxiety agents - therapeutic use (2398) 2398
female (2311) 2311
adult (1753) 1753
benzodiazepines (1578) 1578
middle aged (1394) 1394
index medicus (1095) 1095
psychiatry (1067) 1067
pharmacology & pharmacy (1044) 1044
aged (1017) 1017
animals (970) 970
anti-anxiety agents - administration & dosage (933) 933
anti-anxiety agents - pharmacology (864) 864
anxiety (754) 754
anxiety disorders - drug therapy (680) 680
double-blind method (646) 646
adolescent (585) 585
neurosciences (578) 578
anxiety - drug therapy (534) 534
dose-response relationship, drug (527) 527
rats (485) 485
treatment outcome (473) 473
antidepressive agents - therapeutic use (387) 387
time factors (380) 380
clinical neurology (379) 379
mice (369) 369
benzodiazepines - adverse effects (366) 366
diazepam (362) 362
clinical trials as topic (348) 348
child (305) 305
depression (301) 301
anti-anxiety agents (299) 299
drug interactions (296) 296
double-blind (293) 293
psychiatric status rating scales (290) 290
risk factors (290) 290
benzodiazepines - therapeutic use (283) 283
antidepressive agents - adverse effects (280) 280
hypnotics and sedatives - adverse effects (276) 276
sleep initiation and maintenance disorders - drug therapy (274) 274
behavior, animal - drug effects (267) 267
antipsychotic agents - adverse effects (266) 266
aged, 80 and over (260) 260
drug therapy, combination (260) 260
antipsychotic agents - therapeutic use (259) 259
medicine, general & internal (256) 256
anxiety disorders - psychology (247) 247
diazepam - adverse effects (247) 247
hypnotics and sedatives - therapeutic use (243) 243
lorazepam - adverse effects (240) 240
drug therapy (236) 236
anti-anxiety agents - pharmacokinetics (234) 234
antidepressants (234) 234
panic disorder (210) 210
analysis (205) 205
drugs (202) 202
antianxiety agents (201) 201
alprazolam (200) 200
drug administration schedule (185) 185
depressive disorder - drug therapy (184) 184
prevalence (184) 184
motor activity - drug effects (183) 183
lorazepam - therapeutic use (178) 178
efficacy (176) 176
substance withdrawal syndrome - etiology (176) 176
care and treatment (175) 175
midazolam (174) 174
diazepam - therapeutic use (170) 170
anxiety - psychology (168) 168
research (167) 167
rats, wistar (166) 166
benzodiazepine (164) 164
anxiety disorders (163) 163
prospective studies (162) 162
diazepam - pharmacology (160) 160
pregnancy (160) 160
substance withdrawal syndrome - drug therapy (159) 159
young adult (158) 158
mental disorders - drug therapy (157) 157
administration, oral (155) 155
comorbidity (155) 155
anxiety disorders - diagnosis (154) 154
sleep - drug effects (154) 154
anticonvulsants - therapeutic use (153) 153
disease models, animal (153) 153
psychotropic drugs - adverse effects (153) 153
depression - drug therapy (152) 152
health aspects (151) 151
withdrawal (151) 151
substance withdrawal syndrome - psychology (150) 150
risk (149) 149
serotonin uptake inhibitors - therapeutic use (145) 145
child, preschool (144) 144
generalized anxiety disorder (143) 143
placebos (142) 142
anxieties (140) 140
buspirone (136) 136
medicine & public health (135) 135
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4467) 4467
French (182) 182
German (163) 163
Russian (76) 76
Japanese (48) 48
Spanish (36) 36
Italian (25) 25
Dutch (23) 23
Danish (20) 20
Norwegian (16) 16
Swedish (15) 15
Hungarian (12) 12
Polish (11) 11
Portuguese (7) 7
Chinese (6) 6
Finnish (5) 5
Czech (4) 4
Slovak (4) 4
Romanian (3) 3
Croatian (2) 2
Hebrew (2) 2
Turkish (2) 2
Afrikaans (1) 1
Bulgarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Clinical Psychiatry, ISSN 0160-6689, 09/2010, Volume 71, Issue 9, pp. 1176 - 1186
Journal Article
Neuropharmacology, ISSN 0028-3908, 08/2013, Volume 71, pp. 83 - 97
Serotonin (5-HT) is a neurotransmitter that is involved in many behavioral functions, including the organization of defense, and its putative pathological... 
Fear | Zebrafish | Anxiety | Serotonin | Scototaxis | Geotaxis | 5-HYDROXYTRYPTAMINE RELEASE | RAT | 5-HT1A RECEPTOR ANTAGONISTS | REUPTAKE INHIBITORS | DORSAL RAPHE | ADULT ZEBRAFISH | ELEVATED PLUS-MAZE | T-MAZE | NEUROSCIENCES | IN-VIVO | PHARMACOLOGY & PHARMACY | BRAIN | Anti-Anxiety Agents - administration & dosage | Fenclonine - administration & dosage | Spiro Compounds - therapeutic use | Anxiety - drug therapy | Piperidones - therapeutic use | Serotonin - chemistry | Brain - metabolism | Pyridines - adverse effects | Fenclonine - adverse effects | Behavior, Animal - drug effects | Hyperkinesis - chemically induced | Neurons - metabolism | Serotonin 5-HT1 Receptor Antagonists - administration & dosage | Anti-Anxiety Agents - therapeutic use | Buspirone - therapeutic use | Fluoxetine - adverse effects | Disease Models, Animal | Pyridines - administration & dosage | Nerve Tissue Proteins - agonists | Piperazines - therapeutic use | Piperazines - adverse effects | Extracellular Fluid - drug effects | Brain - drug effects | Serotonin Uptake Inhibitors - administration & dosage | Fluoxetine - administration & dosage | Piperazines - administration & dosage | Fenclonine - therapeutic use | Spiro Compounds - administration & dosage | Piperidones - adverse effects | Hyperkinesis - metabolism | Spiro Compounds - adverse effects | Dose-Response Relationship, Drug | Buspirone - administration & dosage | Protein Isoforms - metabolism | Protein Isoforms - agonists | Anti-Anxiety Agents - adverse effects | Buspirone - adverse effects | Fluoxetine - therapeutic use | Neurons - drug effects | Anxiety - metabolism | Pyridines - therapeutic use | Nerve Tissue Proteins - antagonists & inhibitors | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Serotonin 5-HT1 Receptor Antagonists - adverse effects | Nerve Tissue Proteins - metabolism | Piperidones - administration & dosage | Extracellular Fluid - metabolism | Serotonin 5-HT1 Receptor Antagonists - therapeutic use | Animals | Serotonin - metabolism | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Anxiety - chemically induced | Protein Isoforms - antagonists & inhibitors | Phenols | Buspirone hydrochloride | Fluoxetine
Journal Article
Science, ISSN 0036-8075, 06/2017, Volume 356, Issue 6342, pp. 1084 - 1087
A recent phase 1 trial of the fatty acid amide hydrolase (FAAH) inhibitor BIA 10-2474 led to the death of one volunteer and produced mild-to-severe... 
MOLECULAR CHARACTERIZATION | ENZYME | PAIN | ACID AMIDE HYDROLASE-1 | CLINICAL-TRIAL | MULTIDISCIPLINARY SCIENCES | ANANDAMIDE | RECEPTOR | BLOCKADE | ESTERASE | PF-04457845 | Anti-Anxiety Agents - metabolism | Analgesics - pharmacology | Pyridines - chemistry | Humans | Analgesics - metabolism | Pyridazines - pharmacology | Protein Interaction Maps | Pyridines - adverse effects | Cyclic N-Oxides - adverse effects | Cyclic N-Oxides - pharmacology | Urea - analogs & derivatives | Cyclic N-Oxides - metabolism | Anti-Anxiety Agents - adverse effects | Anti-Anxiety Agents - chemistry | Neurons - metabolism | Neurons - drug effects | Pyridazines - therapeutic use | Analgesics - adverse effects | Anti-Anxiety Agents - pharmacology | Amidohydrolases - antagonists & inhibitors | Cross Reactions | Cyclic N-Oxides - chemistry | Urea - therapeutic use | Pyridines - metabolism | Analgesics - chemistry | Cell Line, Tumor | Pyridines - pharmacology | Clinical Trials, Phase I as Topic | Urea - pharmacology | Amino acid sequence | Methods | Fatty-acid amide hydrolase | Brain | Profiling | Hydrolase | Neurons | Therapeutic applications | Cortex | Nervous system | Tissue analysis | Metabolism | Lipase | Tissues | Fatty acids | Proteins | Neurotoxicity | Pain | Inhibitors | Brain damage | Anxiety | Lipid metabolism | Brain injury | Index Medicus | Drugs | Networks | Proteomics | Amides
Journal Article
JAMA, ISSN 0098-7484, 09/2017, Volume 318, Issue 11, pp. 1047 - 1056
Journal Article
Science, ISSN 0036-8075, 7/2009, Volume 325, Issue 5939, pp. 490 - 493
Journal Article